argenx Bull Case
Here are some ways that investors could benefit from investing in argenx SE:
- The current stock price is around $576, which may present a buying opportunity for investors looking for growth in the biotech sector.
- Institutional investors own over 60% of argenx SE, indicating strong confidence from major financial players in the company's future prospects.
- Recent analyst upgrades have set a consensus price target of approximately $709.18, suggesting potential upside for investors.
- Multiple research firms have issued "buy" ratings, reflecting positive sentiment and expectations for the company's performance.
- argenx SE has shown significant stock performance with a twelve-month high of $678.21, demonstrating its growth potential in the market.